PMID: 9652998Jul 4, 1998Paper

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

Annals of Internal Medicine
B A Neuschwander-TetriE M Brunt

Abstract

Troglitazone is a new drug for the treatment of type 2 diabetes. Although mild liver injury occurred in 1.9% of participants in controlled trials, the U.S. Food and Drug Administration has received reports of five postmarketing cases of severe liver disease that resulted in death or liver transplantation. To report the clinical and histopathologic characteristics of a patient with troglitazone-associated severe liver injury leading to transplantation. Case report. Two university hospitals. A 55-year-old woman taking troglitazone, 400 mg/d, and insulin, 120 U/d. Discontinuation of troglitazone therapy, pretransplantation liver biopsy, and liver transplantation. Early nonspecific symptoms were attributed to other causes and were not evaluated. After the patient had used troglitazone for 3.5 months, massive loss of liver parenchyma and symptoms of liver failure developed, necessitating liver transplantation. Troglitazone may cause subfulminant liver failure.

Citations

Mar 29, 2002·Diabetes/metabolism Research and Reviews·Harold E Lebovitz
Apr 12, 2003·The American Journal of Medicine·David J GrahamParivash Nourjah
Apr 15, 2003·Toxicology and Applied Pharmacology·Kartik ShankarHarihara M Mehendale
Dec 29, 2000·Journal of Hepatology·W M Lee
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·M J Reginato, M A Lazar
May 29, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gerald F DaviesLalita A Bharadwaj
Mar 2, 1999·British Journal of Pharmacology·K PreiningerM Roden
May 8, 1999·British Journal of Haematology·S L FentonC M Bunce
Jun 10, 2000·Journal of Gastroenterology and Hepatology·G Ostapowicz, W M Lee
Dec 6, 2000·Journal of Gastroenterology and Hepatology·D M JiaM Otsuki
Mar 21, 2002·Diabetes, Obesity & Metabolism·W L Isley, J C Oki
May 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·C Day
Sep 7, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·C J Bailey
Sep 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brent A Neuschwander-TetriBruce R Bacon
Aug 2, 2003·The New England Journal of Medicine·William M Lee
Dec 9, 2008·Antioxidants & Redox Signaling·Milton HamblinY Eugene Chen
Oct 7, 2006·Current Opinion in Gastroenterology·W MayoralH Zimmerman
Oct 7, 2006·Current Opinion in Gastroenterology·R J Fontana
Oct 13, 2006·Current Opinion in Gastroenterology·R J Fontana, L G Quallich
Oct 13, 2005·Diabetes, Obesity & Metabolism·Suzanne M Strowig, Philip Raskin
Jul 21, 2000·The Western Journal of Medicine·D Krische
Dec 6, 2008·World Journal of Gastroenterology : WJG·Kazuto Tajiri, Yukihiro Shimizu
Jun 1, 2001·Journal of Endocrinological Investigation·R Perfetti, K Chamie
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·G D DemetriS Singer
Apr 17, 2007·Digestive Diseases and Sciences·Veysel TahanNurdan Tozun
Jan 27, 2010·Digestive Diseases and Sciences·Jeffrey R Lewis, Smruti R Mohanty
Feb 28, 2001·Diabetes, Obesity & Metabolism·C A Reasner
Jul 8, 2005·Journal of Clinical Gastroenterology·Stacy B MeneesRichard H Moseley
Nov 19, 2010·Postgraduate Medicine·Richard PushkinStephanie Kim
Dec 4, 2003·Expert Opinion on Investigational Drugs·Dipak PanigrahyArja Kaipainen
Jun 2, 2007·Expert Opinion on Drug Metabolism & Toxicology·Wei Tang
Feb 25, 2009·Expert Opinion on Drug Safety·C V RizosE N Liberopoulos
Nov 4, 2000·Expert Opinion on Investigational Drugs·E Murphy, J J Nolan
Mar 4, 2011·Expert Opinion on Drug Safety·Keith G Tolman
Jul 7, 2007·Critical Reviews in Toxicology·T WangH M Mehendale
Oct 31, 2003·Expert Opinion on Drug Safety·William L Isley
Jan 1, 2003·Journal of the American Pharmaceutical Association : APhA·John Babb, Victoria J Babb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.